A. Polychronis

Phase I study to determine the safety, tolerability and immunostimulatory activity of thalidomide analogue CC-5013 in patients with metastatic malignant melanoma and other advanced cancers

J. Blake Bartlett, A Michael, Ian Clarke et al. · British Journal of Cancer · 2004 · 139 citations · Full text

Immunology, Pathology, Revimid Trade Mark +16

Management of anastrozole-induced bone loss in breast cancer patients with oral risedronate: results from the ARBI prospective clinical trial

Christos Markopoulos, E. Tzoracoleftherakis, A. Polychronis et al. · Breast Cancer Research · 2010 · 79 citations · Full text

The Effect of Exemestane on the Lipidemic Profile of Postmenopausal Early Breast Cancer Patients: Preliminary Results of the TEAM Greek Sub-study

Christos Markopoulos, A. Polychronis, V. Zobolas et al. · Breast Cancer Research and Treatment · 2005 · 62 citations

Breast Oncology, Oncology, Team Greek Sub-study +11

Lipid changes in breast cancer patients on exemestane treatment: final results of the TEAM Greek substudy

Christos Markopoulos, A. Polychronis, Urania Dafni et al. · Annals of Oncology · 2008 · 53 citations · Full text

Lipid Analysis, Breast Oncology, Oncology +8